| PERIOD ENDING | 25-Sep-09 | 26-Jun-09 | 27-Mar-09 | 26-Dec-08 | | Total Revenue | 4,421,000 | 4,240,000 | 4,150,000 | 4,426,000 | | Cost of Revenue | 2,814,000 | 2,745,000 | 2,715,000 | 2,869,000 | | | Gross Profit | 1,607,000 | 1,495,000 | 1,435,000 | 1,557,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 1,193,000 | 1,124,000 | 1,200,000 | 1,140,000 | | Non Recurring | 99,000 | 32,000 | 2,789,000 | 4,000 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 315,000 | 339,000 | (2,554,000) | 413,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (7,000) | 10,000 | 18,000 | 16,000 | | Earnings Before Interest And Taxes | 308,000 | 349,000 | (2,536,000) | 429,000 | | Interest Expense | 76,000 | 74,000 | 78,000 | 73,000 | | Income Before Tax | 232,000 | 275,000 | (2,614,000) | 356,000 | | Income Tax Expense | 23,000 | 31,000 | (60,000) | 84,000 | | Minority Interest | (2,000) | (1,000) | (1,000) |
-
| | | | Net Income From Continuing Ops | 207,000 | 243,000 | (2,555,000) | 272,000 | | | Non-recurring Events | | Discontinued Operations | (2,000) | 44,000 | (12,000) | 5,000 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 205,000 | 287,000 | (2,567,000) | 277,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $205,000 | $287,000 | ($2,567,000) | $277,000 |
|
1.48% Nasdaq 
Income Statement
